SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage specialty pharmaceutical company focused on developing new treatments for blinding eye diseases, announced today that Al Reaves, Ph.D., Sr. Vice President, Therapeutic Development, Acucela, Inc., will present at the Life Science Innovation Northwest Conference at 10:45 a.m. PST, Room 607 on Wednesday, March 2, 2011 at the Washington State Convention Center in Seattle, Washington.
